TREATMENT OF LIPID AND GLUCOSE METABOLISM DISORDERS WITH DOPAMINE AND SEROTONIN AGONISTS

摘要

The present invention relates to novel, improved methods for regulating in amammal at least one of body weight, body fat, food consumption, lipidmetabolism and glucose metabolism. Administration of a D1 or D2 agonist orboth in the morning, combined with administration of a 5HT1B receptor subtypeagonist at night results in reduction in food consumption, body weight, serumglucose levels and total body fat.